Company intelligence
PharmaLedger Association
A Digital Trust Ecosystem in Healthcare
About PharmaLedger Association
The PharmaLedger Association (PLA) is a not-for-profit with global reach founded in 2022 as the result of the successful completion of the IMI PharmaLedger public-private consortium (2020-2022). PLA’s core objective is to implement and promote a Digital Trust Ecosystem in Healthcare (DTE-H). PLA is a neutral party, pre-competition organization capable of ensuring continuous adherence to antitrust, intellectual property, data privacy, and Computerized System Assurance guidelines. Why is PLA needed? To solve ecosystem-wide problems that cannot be solved by silos or single organizations. It takes an ecosystem to sustain a trusted, shared infrastructure for secure data exchange in healthcare. Any organization or company connected and impacted by the healthcare industry can become a member of PLA, including manufacturers, wholesalers, distributors, pharmacy chains, clinics, hospitals, technology and other specialized service providers, healthcare organizations, NGOs, and patient organizations, among others. Our associated organizations have the opportunity to pool resources, share risks and be an at the forefront of the creation of the modern healthcare experience, Healthcare 4.0 is here! Join us and learn more at: https://pharmaledger.org/
Verified activity
Signals from PharmaLedger Association
7 published signals
Presence & Recognition
PharmaLedger Association co-sponsors the event in Reinach on 24 September to exchange practical insights and explore collaborative efforts for pharmaceutical supply chains.
Reported by Stefan Schwarzfischer, Dr.-Eng.
Research & Knowledge
PharmaLedger Association published the final part of its four-part series examining why progress remains slow and setting out a practical acceleration agenda.
Reported by PharmaLedger Association
Legal & Regulatory
PharmaLedger Association reports that the European Medicines Agency published its ePI implementation roadmap in the past 18 months.
Reported by PharmaLedger Association
Legal & Regulatory
PharmaLedger Association reports that the EU pharmaceutical legislation reached political agreement.
Reported by PharmaLedger Association
Legal & Regulatory
PharmaLedger Association reports that six new markets activated serialisation requirements.
Reported by PharmaLedger Association
Legal & Regulatory
PharmaLedger Association reports that FDA and EMA released joint AI governance principles.
Reported by PharmaLedger Association
Legal & Regulatory
PharmaLedger Association reports that DSCSA reached full enforcement in the US.
Reported by PharmaLedger Association